DG
Therapeutic Areas
Biogen Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Multiple Sclerosis Portfolio | Multiple Sclerosis | Commercial |
| Spinal Muscular Atrophy Program | Spinal Muscular Atrophy | Commercial |
| Alzheimer's Disease Program | Alzheimer's Disease and Dementia | Phase 3 |
| ALS Program | Amyotrophic Lateral Sclerosis | Multiple Phases |
| Friedreich Ataxia Treatment | Friedreich Ataxia | Approved |
| Lupus Program | Systemic Lupus | Phase 3 |
| Postpartum Depression Program | Postpartum Depression | Clinical Development |
| Kidney Disease Portfolio | Immune-mediated Kidney Disease | Clinical Development |